Measuring transparency to improve good governance in the public pharmaceutical sector : Syrian Arab Republic

AL HAKEEM, Souheila
Publication Date 

"This report presents the findings of the first phase of the [World Health Organization's] national Good Governance for Medicines programme in the Syrian Arab Republic. The assessment aims to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. In the Syrian Arab Republic, the assessment looked at eight functions: medicines registration, licensing of pharmaceutical establishments, inspection of pharmaceutical establishments, promotion, selection, clinical trials, procurement and distribution"

View webpage for full text 
Regional Focus 
Country focus 
Type of material 
Content type